journal article·2022-06-22

NIR-II Responsive Molybdenum Dioxide Nanosystem Manipulating Cellular Immunogenicity for Enhanced Tumor Photoimmunotherapy

Peilin Lan, Haolin Chen, Yanxian Guo, Yang Li, Ying Zheng, Yue Zhang, Meng Li, Zhouyi Guo, Zhiming Liu

Nano Letters· Volume 22· Issue 12
Publisher page

Abstract

Photothermal therapy (PTT) in the second near-infrared (NIR-II) window has emerged as a better candidate for deep-tissue tumor elimination. More interestingly, the photothermal ablated tumor cells also manifest somewhat immunostimulation potency to elicit antitumor immunity, although most dying cells are undergoing apoptosis that is commonly considered as immunologically silent. Here, a NIR-II responsive nanosystem is established for tumor photoimmunotherapy using molybdenum dioxide (MoO2) nanodumbbells as the nanoconverter. Meanwhile, an apoptosis-blocking strategy is proposed to regulate the cell death pattern under NIR-II laser irradiation in order to improve the immunogenic cell death. The nanoformulation can efficiently block caspase 8-dependent apoptotic pathway in photothermal ablated tumor cells and transform into more immunogenic death patterns, thereby activating systemic immunity to inhibit tumor growth and metastasis. In addition, this strategy also helps enhance the body’s responses to α-PD-1 immune checkpoint inhibitor, which implies a potential optimal combination for cancer immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

MOE Key Laboratory of Laser Life Science and Guangdong Provincial Key Laboratory of Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, China

Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China

Funding

Guangdong Science and Technology Department · Guangzhou Municipal Science and Technology Bureau · Science, Technology and Innovation Commission of Shenzhen Municipality · National Natural Science Foundation of China · Key Laboratory of Optoelectronic Science and Technology for Medicine, Fujian Normal University · Seventh Affiliated Hospital, Sun Yat-sen University

References (54)

Show source-provided references
1. 10.1039/D0CS00664E10.1039/D0CS00664E ↗
2. 10.1016/j.biomaterials.2020.12045910.1016/j.biomaterials.2020.120459 ↗
3. 10.1002/adfm.20210162510.1002/adfm.202101625 ↗
4. 10.1002/advs.20190257610.1002/advs.201902576 ↗
5. 10.1088/0022-3727/38/15/00410.1088/0022-3727/38/15/004 ↗
6. 10.1039/C8CS00494C10.1039/C8CS00494C ↗
7. Zhou C. · Adv. Mater. · 2021 · 33 · e200653210.1002/adma.202006532 ↗
8. 10.1002/adma.20200854010.1002/adma.202008540 ↗
9. 10.1002/anie.20200047410.1002/anie.202000474 ↗
10. 10.1021/acs.nanolett.9b0036410.1021/acs.nanolett.9b00364 ↗
11. 10.1021/acsnano.9b0045210.1021/acsnano.9b00452 ↗
12. 10.1002/advs.20200119110.1002/advs.202001191 ↗
13. 10.1007/s40843-019-1272-010.1007/s40843-019-1272-0 ↗
14. 10.1002/anie.20200838610.1002/anie.202008386 ↗
15. 10.1016/j.biomaterials.2021.12078810.1016/j.biomaterials.2021.120788 ↗
16. 10.1021/acsnano.8b0737110.1021/acsnano.8b07371 ↗
17. 10.1039/C9CS00773C10.1039/C9CS00773C ↗
18. 10.1039/D0TB00824A10.1039/D0TB00824A ↗
19. 10.1002/anie.20180488210.1002/anie.201804882 ↗
20. 10.1021/acs.accounts.9b0027310.1021/acs.accounts.9b00273 ↗
21. 10.1038/s41467-021-21047-010.1038/s41467-021-21047-0 ↗
22. 10.1038/s41467-021-23194-w10.1038/s41467-021-23194-w ↗
23. 10.1038/s41571-020-0413-z10.1038/s41571-020-0413-z ↗
24. 10.1038/s41418-018-0214-410.1038/s41418-018-0214-4 ↗
25. 10.1016/j.trecan.2020.02.01510.1016/j.trecan.2020.02.015 ↗
26. 10.1002/anie.20210639210.1002/anie.202106392 ↗
27. 10.1136/jitc-2019-00033710.1136/jitc-2019-000337 ↗
28. 10.1002/advs.20180215710.1002/advs.201802157 ↗
29. 10.1016/j.cej.2020.12431410.1016/j.cej.2020.124314 ↗
30. 10.1186/s13045-020-00946-710.1186/s13045-020-00946-7 ↗
31. 10.1158/2159-8290.CD-20-080510.1158/2159-8290.CD-20-0805 ↗
32. 10.1126/sciimmunol.aaw200410.1126/sciimmunol.aaw2004 ↗
33. 10.1016/j.celrep.2016.03.03710.1016/j.celrep.2016.03.037 ↗
34. 10.1002/adma.20190795310.1002/adma.201907953 ↗
35. 10.1002/advs.20210184010.1002/advs.202101840 ↗
36. 10.1002/adfm.20210633210.1002/adfm.202106332 ↗
37. 10.1021/acs.nanolett.1c0279010.1021/acs.nanolett.1c02790 ↗
38. 10.1038/s41586-019-1752-810.1038/s41586-019-1752-8 ↗
39. 10.1038/s41586-019-1548-x10.1038/s41586-019-1548-x ↗
40. 10.1038/s41586-019-1770-610.1038/s41586-019-1770-6 ↗
41. 10.1016/j.bioactmat.2020.08.03410.1016/j.bioactmat.2020.08.034 ↗
42. 10.1073/pnas.171442111510.1073/pnas.1714421115 ↗
43. 10.1039/C8CS00342D10.1039/C8CS00342D ↗
44. 10.1038/s41467-020-20243-810.1038/s41467-020-20243-8 ↗
45. 10.1002/adma.20200503610.1002/adma.202005036 ↗
46. 10.1021/acsnano.0c0519410.1021/acsnano.0c05194 ↗
47. 10.1002/adma.20180588810.1002/adma.201805888 ↗
48. 10.1038/nrc338010.1038/nrc3380 ↗
49. 10.1002/adfm.20190974510.1002/adfm.201909745 ↗
50. 10.1002/adma.20210256210.1002/adma.202102562 ↗
51. 10.1002/adfm.20210460710.1002/adfm.202104607 ↗
52. 10.1039/C8CS00473K10.1039/C8CS00473K ↗
53. 10.1002/adma.20200478810.1002/adma.202004788 ↗
54. 10.1038/s41586-020-2911-710.1038/s41586-020-2911-7 ↗